Closer to home: local care improves compliance with RSV prophylaxis in high-risk infants.
Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska 99508, USA. ris2@cdc.gov
Rosalyn J
RJ
Singleton
Dana
D
Bruden
Lisa
L
Brooks
Jenni
J
DeLeon
Anna
A
Vercelline
Jay C
JC
Butler
D000413:Alaska; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D003153:Community Health Services; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D000069455:Palivizumab; D010349:Patient Compliance; D012136:Respiratory Syncytial Viruses / Q000187:drug effects*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069455:Palivizumab